First Quarter 2015
Financial Results Announced
Quarter highlighted by strong global revenues, U.S. lung cancer approval for OPDIVO®, business development
2014 Annual Report Delivering Transformational Medicines to PatientsLearn more
about how Bristol-Myers Squibb is working hard
to develop innovative medicines that have the potential to
transform the lives of the people we serve.